Ledger. Australian venture funding, tracked

Startup · $500k raised

Aspecthera

Novel eye-drop therapy for non-proliferative diabetic retinopathy

What Aspecthera bought

Companies Aspecthera acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.

Company KindAnnounced Price Sources
Aspecthera is not recorded as having acquired anything.

Something wrong? Tell us